Pages that link to "Q57043593"
Jump to navigation
Jump to search
The following pages link to Cognitive functioning and positive and negative symptoms in schizophrenia (Q57043593):
Displaying 50 items.
- Comparison of auditory and visual oddball fMRI in schizophrenia (Q27303961) (← links)
- BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies (Q28943394) (← links)
- Negative symptoms and cognitive deficits: what is the nature of their relationship? (Q30491348) (← links)
- Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources (Q30711476) (← links)
- A virtual reality task based on animal research - spatial learning and memory in patients after the first episode of schizophrenia (Q33668339) (← links)
- Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis (Q33675212) (← links)
- Gyrification and neural connectivity in schizophrenia (Q33801763) (← links)
- Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. (Q33921161) (← links)
- Is it time to develop a new cognitive therapy for psychosis--cognitive remediation therapy (CRT)? (Q34101219) (← links)
- Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. (Q34264101) (← links)
- Subtyping schizophrenia: implications for genetic research (Q34542103) (← links)
- Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits (Q35177285) (← links)
- Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms (Q35187199) (← links)
- Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia (Q35207454) (← links)
- Comparison of Visuospatial and Verbal Abilities in First Psychotic Episode of Schizophrenia Spectrum Disorder: Impact on Global Functioning and Quality of Life. (Q36381682) (← links)
- Effortful cognitive resource allocation and negative symptom severity in chronic schizophrenia (Q36853259) (← links)
- Evaluation of efficacy, safety, and cognitive profile of amisulpride per se and its comparison with olanzapine in newly diagnosed schizophrenic patients in an 8-week, double-blind, single-centre, prospective clinical trial (Q36858373) (← links)
- Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial (Q36940014) (← links)
- A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia (Q37212798) (← links)
- Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability (Q37302635) (← links)
- Memory-prediction errors and their consequences in schizophrenia (Q37539797) (← links)
- Positive schizotypy and negative schizotypy are associated with differential patterns of episodic memory impairment (Q38373385) (← links)
- The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity (Q38400283) (← links)
- Slowed lexical access is uniquely associated with positive and disorganised symptoms in schizophrenia (Q38408136) (← links)
- Symptomatic Remission and Counterfactual Reasoning in Schizophrenia (Q38767226) (← links)
- Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients : estimates from a prospective naturalistic study (Q40352853) (← links)
- The Relationship between Attention/Vigilance and Symptom Severity in Schizophrenic Patients (Q41892834) (← links)
- Wisconsin Card Sorting Test performance impairment in schizophrenia: An Indian study report (Q42146989) (← links)
- Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? (Q42544021) (← links)
- The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements (Q42688865) (← links)
- Premorbid IQ varies across different definitions of schizophrenia. (Q42945161) (← links)
- Is executive impairment associated with schizophrenic syndromes? A meta-analysis (Q43513717) (← links)
- Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications (Q44449175) (← links)
- Schizophrenia and memory impairment: evidence for a neurocognitive subtype. (Q46022887) (← links)
- Language context processing deficits in schizophrenia: The role of attentional engagement. (Q46480228) (← links)
- Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study (Q48144270) (← links)
- Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage (Q48165305) (← links)
- Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia (Q48418949) (← links)
- Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms (Q48449814) (← links)
- Neuropsychological correlates of positive vs. negative schizophrenic symptomatology (Q48502516) (← links)
- Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease (Q48588035) (← links)
- Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases. (Q48634450) (← links)
- Baseline neurocognitive deficits in the CATIE schizophrenia trial. (Q50732363) (← links)
- Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs. (Q50969035) (← links)
- Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia (Q51059778) (← links)
- Nonverbal social perception and symptomatology in schizophrenia. (Q51961759) (← links)
- Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. (Q51973672) (← links)
- Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. (Q51978430) (← links)
- Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study. (Q52005610) (← links)
- Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. (Q52167386) (← links)